Clinical Study of Ligustrazine in Treating Alcohol Addiction
Status:
Recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
Alcohol consumption is one of the most important risk factors for chronic non-communicable
diseases in the population, and it is also the main cause of death from cancer,
cardiovascular disease and lung disease, causing serious health, economic and social
problems. The current alcohol-abstinence drugs have limited therapeutic effects and still
present a high relapse rate. It is an urgent need to develop effective drugs for the
treatment of alcohol addiction. The multimodal mechanism of action of ligustrazine in the
central nervous system indicates that ligustrazine is expected to be developed as a potential
therapeutic drug for alcohol addiction. Our study investigated the therapeutic effect of
ligustrazine on subjects with alcohol addiction and the mechanism of multimodal brain imaging
by administering ligustrazine, in order to develop new targeted drugs for alcohol treatment
and provide more effective diagnosis and treatment methods for clinical treatment.